Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Many New Jersey patients are transitioning to dual-agonist therapies because clinical trials, such as the SURMOUNT-1 study, demonstrated weight loss results exceeding 20% in 72 weeks
These factors alone make this a high-risk period for the return or development of disordered eating and body image distress
Expect appetite to increase notably in the weeks following discontinuation
In another case, a 37-year-old woman with obesity administered herself with 1 milliliter of semaglutide when the intended dose was 0.1 milliliter
Psychoneuroendocrinology 2013 doi:pii:S0306-4530(13)00017-6
US$ 23.87
US$ 23.26
US$ 22.75
US$ 21.28
